BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35412314)

  • 1. Prediction of In Vivo Pharmacokinetic Parameters and Time-Exposure Curves in Rats Using Machine Learning from the Chemical Structure.
    Obrezanova O; Martinsson A; Whitehead T; Mahmoud S; Bender A; Miljković F; Grabowski P; Irwin B; Oprisiu I; Conduit G; Segall M; Smith GF; Williamson B; Winiwarter S; Greene N
    Mol Pharm; 2022 May; 19(5):1488-1504. PubMed ID: 35412314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Comparison of Machine Learning and Mechanistic In Vitro-In Vivo Extrapolation Models for the Prediction of Human Intrinsic Clearance.
    Keefer CE; Chang G; Di L; Woody NA; Tess DA; Osgood SM; Kapinos B; Racich J; Carlo AA; Balesano A; Ferguson N; Orozco C; Zueva L; Luo L
    Mol Pharm; 2023 Nov; 20(11):5616-5630. PubMed ID: 37812508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
    Kosugi Y; Hosea N
    Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure.
    Pillai N; Abos A; Teutonico D; Mavroudis PD
    Clin Transl Sci; 2024 May; 17(5):e13824. PubMed ID: 38752574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) Modeling Predictions to Inform Early Drug Discovery.
    Naga D; Parrott N; Ecker GF; Olivares-Morales A
    Mol Pharm; 2022 Jul; 19(7):2203-2216. PubMed ID: 35476457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Another string to your bow: machine learning prediction of the pharmacokinetic properties of small molecules.
    Bassani D; Parrott NJ; Manevski N; Zhang JD
    Expert Opin Drug Discov; 2024 Jun; 19(6):683-698. PubMed ID: 38727016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologically Based Models? A Feasibility Study Based on 12 Development Compounds.
    Parrott N; Manevski N; Olivares-Morales A
    Mol Pharm; 2022 Nov; 19(11):3858-3868. PubMed ID: 36150125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Oral Pharmacokinetics Using a Combination of In Silico Descriptors and In Vitro ADME Properties.
    Kosugi Y; Hosea N
    Mol Pharm; 2021 Mar; 18(3):1071-1079. PubMed ID: 33512165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Predictions of Nonclinical Pharmacokinetics at the Drug Design Stage.
    Stoyanova R; Katzberger PM; Komissarov L; Khadhraoui A; Sach-Peltason L; Groebke Zbinden K; Schindler T; Manevski N
    J Chem Inf Model; 2023 Jan; 63(2):442-458. PubMed ID: 36595708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Oral Bioavailability in Rats: Transferring Insights from in Vitro Correlations to (Deep) Machine Learning Models Using in Silico Model Outputs and Chemical Structure Parameters.
    Schneckener S; Grimbs S; Hey J; Menz S; Osmers M; Schaper S; Hillisch A; Göller AH
    J Chem Inf Model; 2019 Nov; 59(11):4893-4905. PubMed ID: 31714067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence for compound pharmacokinetics prediction.
    Obrezanova O
    Curr Opin Struct Biol; 2023 Apr; 79():102546. PubMed ID: 36804676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine Learning Models for Human
    Miljković F; Martinsson A; Obrezanova O; Williamson B; Johnson M; Sykes A; Bender A; Greene N
    Mol Pharm; 2021 Dec; 18(12):4520-4530. PubMed ID: 34758626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug design tools--in silico, in vitro and in vivo ADME/PK prediction and interpretation: is PK in monkey an essential part of a good human PK prediction?
    Hosea NA
    Curr Top Med Chem; 2011; 11(4):351-7. PubMed ID: 21320064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Total Drug Clearance in Humans Using Animal Data: Proposal of a Multimodal Learning Method Based on Deep Learning.
    Iwata H; Matsuo T; Mamada H; Motomura T; Matsushita M; Fujiwara T; Kazuya M; Handa K
    J Pharm Sci; 2021 Apr; 110(4):1834-1841. PubMed ID: 33497658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Bioavailability and Disposition protocol: A novel higher throughput approach to assess pharmacokinetics and steady-state brain distribution with reduced animal usage.
    Fu T; Gao R; Scott-Stevens P; Chen Y; Zhang C; Wang J; Summerfield S; Liu H; Sahi J
    Eur J Pharm Sci; 2018 Sep; 122():13-21. PubMed ID: 29857045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties.
    Di Lascio E; Gerebtzoff G; Rodríguez-Pérez R
    Mol Pharm; 2023 Mar; 20(3):1758-1767. PubMed ID: 36745394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Physico-Chemical ADMET Endpoints with Multitask Graph Convolutional Networks.
    Montanari F; Kuhnke L; Ter Laak A; Clevert DA
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31877719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery.
    Lucas AJ; Sproston JL; Barton P; Riley RJ
    Expert Opin Drug Discov; 2019 Dec; 14(12):1313-1327. PubMed ID: 31538500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.